Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
DHR - Danaher Corporation
Market Cap 190.40B P/E 30.23 EPS this Y - Ern Qtrly Grth -18.00%
Income 4.06B Forward P/E 29.24 EPS next Y 14.20% 50D Avg Chg 7.00%
Sales 23.57B PEG 5.26 EPS past 5Y 12.18% 200D Avg Chg 3.00%
Dividend N/A Price/Book 3.68 EPS next 5Y 6.88% 52W High Chg -15.00%
Recommedations 2.10 Quick Ratio 0.85 Shares Outstanding 722.21M 52W Low Chg 17.00%
Insider Own 11.00% ROA 3.98% Shares Float 641.79M Beta 0.86
Inst Own 82.72% ROE 7.98% Shares Shorted/Prior 7.01M/6.39M Price 257.87
Gross Margin 59.78% Profit Margin 17.83% Avg. Volume 3,288,670 Target Price 288.32
Oper. Margin 20.34% Earnings Date Oct 22 Volume 2,545,214 Change 1.13%
Healthcare | Diagnostics & Research | United States
About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Danaher Corporation News
12/23/24 Jim Cramer Reports That Danaher Corporation (DHR)’s China Core Revenue Dropped By A ‘High-single-digit’ Percent In Q3
12/21/24 Cramer Criticizes Danaher (DHR) for Lackluster Performance and Unimpressive Guidance
12/15/24 Why Danaher Corporation (DHR) Is the Best Stock to Buy for the Long-Term According to Charles Akre?
12/13/24 Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
12/11/24 Here’s Why Parnassus Growth Equity Fund Sold Danaher Corp. (DHR)
12/10/24 Danaher Announces Quarterly Dividend
12/10/24 Here's Why You Should Avoid Investing in Danaher Stock Right Now
11/26/24 Danaher to Present at Evercore ISI HealthCONx Conference
11/22/24 Danaher Corp (NYSE:DHR): A Bullish Investment Perspective
11/19/24 Danaher Corporation (DHR) Highlighted Milestones in its 2024 Corporate Sustainability Report
11/01/24 Here’s Why Baron Health Care Fund Added Danaher Corporation (DHR) to its Portfolio
10/28/24 Danaher (DHR) Reliance on International Sales: What Investors Need to Know
10/26/24 Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.
10/24/24 Danaher price target raised to $265 from $250 at Stifel
10/23/24 Danaher Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
10/23/24 Danaher Corp (DHR) Q3 2024 Earnings Call Highlights: Resilient Performance Amidst Market Challenges
10/23/24 Decoding Danaher Corp (DHR): A Strategic SWOT Insight
10/22/24 Q3 2024 Danaher Corp Earnings Call
10/22/24 Jim Cramer on Danaher Corporation (DHR): ‘It’s A Very Important Position’
10/22/24 Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating
DHR Chatroom

User Image Stocksrunner Posted - 5 days ago

looking for potential entry points? here are a few stocks testing their support levels 👇 $ACHC struggling but holding strong, watch for a bounce $AVAV great price action, keep an eye on this for a reversal $DHR steady with good volume – could be a good entry $HUM strong fundamentals, a solid pick if it dips timing is key—keep an eye on those support zones! make sure to act when momentum starts to shift

User Image Estimize Posted - 1 week ago

Wall St is expecting 2.14 EPS for $DHR Q4 [Reporting 02/04 BMO] http://www.estimize.com/intro/dhr?chart=historical&metric_name=eps&utm_cont

User Image Berk33 Posted - 1 week ago

$DHR $SPY CHOO CHOOOO!! ALL ABOOAARRDD!!! BULLS LOOKING TO TAKE THIS PUPPY NORTH TO 244$ By Dec 20th 🤑☺️

User Image trade2livehappy Posted - 2 weeks ago

$TMO $DHR $LLY $MOH $UNH Isn’t this big news?

User Image Inmyzone Posted - 2 weeks ago

$DHR 300 next week

User Image trade2livehappy Posted - 2 weeks ago

$DHR chart looks ugly. TMO is much better

User Image puckfan Posted - 2 weeks ago

$DHR Nice call, Cramer. 😆🤣😂

User Image trade2livehappy Posted - 2 weeks ago

$DHR any news here??

User Image iQuicky Posted - 2 weeks ago

$DHR on sale

User Image Colostrum Posted - 2 weeks ago

$DHR Why down so sharply??

User Image pilobious Posted - 2 weeks ago

$DHR anti-drug kook RFK Jr killing health stocks v.

User Image mikeharrisNY Posted - 2 weeks ago

Currently, I'm considering $AMD $DHR $INTC $BA $QCOM as relief rally candidates, according to the analysis. Never put all eggs in one basket.

User Image SonGoku Posted - 2 weeks ago

Cramer says buy $DHR

User Image Colostrum Posted - 2 weeks ago

$DHR Anyone know why down today?

User Image Inmyzone Posted - 11/26/24

$DHR swing trade to 300

User Image etradebaby Posted - 1 month ago

$DHR long more here. oversold. Been in this tor like 8 yrs. solid company even with the volatility

User Image TheMarketMaster Posted - 1 month ago

$DHR easy money

User Image TheMarketMaster Posted - 1 month ago

$DHR

User Image TheMarketMaster Posted - 1 month ago

$DHR that 234 is the resistance devil. Once it can overcome it. It’s off to the races. $230 average with 1,000 shares

User Image DollarRain Posted - 1 month ago

$DHR Is this uptrend for real. We’re about to be released from purgatory so fast😂

User Image Mr_Diamond_Hands36 Posted - 1 month ago

$DHR 237 a few minutes ago, can someone explain? Need this at open 🤞🏽

User Image NVDAMillionaire Posted - 1 month ago

$DHR Danaher Corporation (DHR): A Powerhouse Poised for Long-Term Success https://beyondspx.com/article/danaher-corporation-dhr-a-diversified-leader-in-scientific-instruments-and-diagnostics

User Image TheMarketMaster Posted - 1 month ago

$DHR I got 1,000 shares at 230. In.

User Image Mr_Diamond_Hands36 Posted - 1 month ago

$DHR https://www.tipranks.com/stocks/dhr/forecast#

User Image Mr_Diamond_Hands36 Posted - 1 month ago

$DHR price target $265, 14 strong buy recommendations!

User Image DollarRain Posted - 1 month ago

$DHR where is the bottom for this?… it’s been sinking nonstop in the last 3wks.

User Image swingingtech Posted - 1 month ago

$DHR https://wallstreetwaves.com/danaher-stock-wall-street-analysts-price-targets-explained/

User Image Nosh Posted - 1 month ago

$DHR Added here...

User Image grnstock Posted - 1 month ago

$DHR added. GL

User Image GettnFibbywIT Posted - 1 month ago

$DHR $XLV $SPY DHR - Might be a logical area for a short term trading bounce......

Analyst Ratings
Evercore ISI Group Outperform Oct 1, 24
Stephens & Co. Overweight Oct 1, 24
RBC Capital Outperform Sep 6, 24
Wells Fargo Equal-Weight Aug 27, 24
Baird Outperform Jul 24, 24
RBC Capital Outperform Jul 24, 24
Barclays Equal-Weight Jul 24, 24
Leerink Partners Outperform Jul 24, 24
Stifel Hold Jul 24, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gutierrez-Ramos Jose-Carlos SVP, Chief Science O.. SVP, Chief Science Officer Aug 21 Sell 250.54 590 147,819 6,939 08/22/23
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 26 Sell 263.42 22,439 5,910,881 88,689 07/27/23
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 26 Option 56.7 22,439 1,272,291 111,128 07/27/23
List Teri Director Director Jul 26 Sell 263.3 3,490 918,917 17,494 07/27/23
List Teri Director Director Jul 26 Option 50.8 3,490 177,292 20,984 07/27/23
Raskas Daniel SVP - Corporate Deve.. SVP - Corporate Development May 31 Sell 228.5 19,847 4,535,040 38,673 06/01/23
Raskas Daniel SVP - Corporate Deve.. SVP - Corporate Development May 31 Option 57.9 19,847 1,149,141 58,520 06/01/23
LOHR WALTER G Director Director May 05 Sell 240.88 3,490 840,671 12,115 05/08/23
LOHR WALTER G Director Director May 05 Option 50.8 3,490 177,292 15,605 05/08/23
Couchara Georgeann SVP, Human Resources SVP, Human Resources Nov 15 Sell 271.61 1,884 511,713 2,588 11/16/22
McGrew Matthew EVP & Chief Financia.. EVP & Chief Financial Officer Nov 11 Option 57.3 18,935 1,084,976 40,847 11/14/22
McGrew Matthew EVP & Chief Financia.. EVP & Chief Financial Officer Nov 11 Sell 274.67 18,935 5,200,876 29,634 11/14/22
Honeycutt Jennifer Executive Vice Presi.. Executive Vice President Nov 10 Option 65.83 8,211 540,530 15,373 11/14/22
Honeycutt Jennifer Executive Vice Presi.. Executive Vice President Nov 10 Sell 265 8,211 2,175,915 7,162 11/14/22
Blair Rainer President & CEO President & CEO Aug 15 Option 68.29 25,000 1,707,250 104,739 08/17/22
Blair Rainer President & CEO President & CEO Aug 15 Sell 300 25,000 7,500,000 79,739 08/17/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 25 Sell 271.56 12,000 3,258,720 74,398 07/26/22
LOHR WALTER G Director Director Jul 22 Option 38.64 4,548 175,735 16,663 07/25/22
LOHR WALTER G Director Director Jul 22 Sell 273.84 3,906 1,069,619 12,115 07/25/22
SCHWIETERS JOHN T Director Director Jul 13 Option 38.64 4,548 175,735 18,663 07/14/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Apr 25 Sell 255.735 6,500 1,662,278 86,398 04/27/22
Ellis Brian W Senior Vice Presiden.. Senior Vice President - GC Feb 02 Sell 293.9884 5,365 1,577,248 12,374 02/03/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jan 31 Option 46.13 20,508 946,034 84,351 02/02/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jan 31 Sell 285.24 20,508 5,849,702 63,843 02/02/22
RALES MITCHELL P Chairman of Exec. Co.. Chairman of Exec. Committee Nov 02 Sell 308.71 1,225,841 378,429,375 11/04/21
LUTZ ROBERT S SVP-Chief Accounting.. SVP-Chief Accounting Officer Oct 27 Option 46.13 24,594 1,134,521 43,544 10/27/20
LUTZ ROBERT S SVP-Chief Accounting.. SVP-Chief Accounting Officer Oct 27 Sell 234.37 24,594 5,764,096 18,950 10/27/20
COMAS DANIEL L EVP EVP Oct 27 Option 65.83 54,402 3,581,284 109,607 10/27/20
COMAS DANIEL L EVP EVP Oct 27 Sell 233.99 54,402 12,729,524 92,683 10/27/20